Timber Creek Capital Management LLC Purchases 197 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Timber Creek Capital Management LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,232 shares of the healthcare conglomerate’s stock after buying an additional 197 shares during the period. UnitedHealth Group comprises 1.8% of Timber Creek Capital Management LLC’s portfolio, making the stock its 17th largest holding. Timber Creek Capital Management LLC’s holdings in UnitedHealth Group were worth $6,188,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of UNH. AMF Tjanstepension AB grew its stake in UnitedHealth Group by 88.0% during the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after acquiring an additional 121,180 shares in the last quarter. Hudson Value Partners LLC lifted its position in UnitedHealth Group by 8.3% in the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after buying an additional 82 shares during the last quarter. Wealth Group Ltd. raised its position in UnitedHealth Group by 4.0% in the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock worth $1,039,000 after purchasing an additional 68 shares during the period. Howard Capital Management Group LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $341,000. Finally, Trilogy Capital Inc. boosted its stake in shares of UnitedHealth Group by 6.3% during the third quarter. Trilogy Capital Inc. now owns 857 shares of the healthcare conglomerate’s stock valued at $501,000 after purchasing an additional 51 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 4.2 %

UNH stock opened at $501.52 on Wednesday. The firm has a 50 day simple moving average of $521.08 and a 200-day simple moving average of $562.03. The company has a market capitalization of $461.54 billion, a P/E ratio of 32.36, a PEG ratio of 1.43 and a beta of 0.61. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company earned $5.83 earnings per share. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently weighed in on UNH. Piper Sandler decreased their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. KeyCorp reiterated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Wells Fargo & Company reduced their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Finally, HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.